These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 22995303
1. Targeting SMARCAL1 as a novel strategy for cancer therapy. Zhang L, Fan S, Liu H, Huang C. Biochem Biophys Res Commun; 2012 Oct 19; 427(2):232-5. PubMed ID: 22995303 [Abstract] [Full Text] [Related]
2. Deficiency of smarcal1 causes cell cycle arrest and developmental abnormalities in zebrafish. Huang C, Gu S, Yu P, Yu F, Feng C, Gao N, Du J. Dev Biol; 2010 Mar 01; 339(1):89-100. PubMed ID: 20036229 [Abstract] [Full Text] [Related]
3. SMARCAL1 and replication stress: an explanation for SIOD? Bansbach CE, Boerkoel CF, Cortez D. Nucleus; 2010 Mar 01; 1(3):245-8. PubMed ID: 21327070 [Abstract] [Full Text] [Related]
5. DNA structure and integrity checkpoints during the cell cycle and their role in drug targeting and sensitivity of tumor cells to anticancer treatment. Skladanowski A, Bozko P, Sabisz M. Chem Rev; 2009 Jul 01; 109(7):2951-73. PubMed ID: 19522503 [No Abstract] [Full Text] [Related]
10. Targeting DNA damage and repair: embracing the pharmacological era for successful cancer therapy. Aziz K, Nowsheen S, Pantelias G, Iliakis G, Gorgoulis VG, Georgakilas AG. Pharmacol Ther; 2012 Mar 01; 133(3):334-50. PubMed ID: 22197993 [Abstract] [Full Text] [Related]
11. Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance. Zhu Y, Hu J, Hu Y, Liu W. Cancer Treat Rev; 2009 Nov 01; 35(7):590-6. PubMed ID: 19635647 [Abstract] [Full Text] [Related]
12. Anticancer activities of histone deacetylase inhibitors. Bolden JE, Peart MJ, Johnstone RW. Nat Rev Drug Discov; 2006 Sep 01; 5(9):769-84. PubMed ID: 16955068 [Abstract] [Full Text] [Related]
13. [SMARCAL1, roles and mechanisms in genome stability maintenance]. Wen YL, Lü KN, Xu XK, Zhang X, Ding L, Pan XF. Yi Chuan; 2019 Dec 20; 41(12):1084-1098. PubMed ID: 31857280 [Abstract] [Full Text] [Related]
14. Helicases as prospective targets for anti-cancer therapy. Gupta R, Brosh RM. Anticancer Agents Med Chem; 2008 May 20; 8(4):390-401. PubMed ID: 18473724 [Abstract] [Full Text] [Related]
15. A structure-specific nucleic acid-binding domain conserved among DNA repair proteins. Mason AC, Rambo RP, Greer B, Pritchett M, Tainer JA, Cortez D, Eichman BF. Proc Natl Acad Sci U S A; 2014 May 27; 111(21):7618-23. PubMed ID: 24821763 [Abstract] [Full Text] [Related]
16. The SIOD disorder protein SMARCAL1 is an RPA-interacting protein involved in replication fork restart. Ciccia A, Bredemeyer AL, Sowa ME, Terret ME, Jallepalli PV, Harper JW, Elledge SJ. Genes Dev; 2009 Oct 15; 23(20):2415-25. PubMed ID: 19793862 [Abstract] [Full Text] [Related]
17. Targeting cancer with small-molecular-weight kinase inhibitors. Fabbro D, Cowan-Jacob SW, Möbitz H, Martiny-Baron G. Methods Mol Biol; 2012 Oct 15; 795():1-34. PubMed ID: 21960212 [Abstract] [Full Text] [Related]
18. DNA repair helicases as targets for anti-cancer therapy. Gupta R, Brosh RM. Curr Med Chem; 2007 Oct 15; 14(5):503-17. PubMed ID: 17346143 [Abstract] [Full Text] [Related]
19. SMARCAL1 and telomeres: Replicating the troublesome ends. Poole LA, Cortez D. Nucleus; 2016 May 03; 7(3):270-4. PubMed ID: 27355316 [Abstract] [Full Text] [Related]
20. The annealing helicase SMARCAL1 maintains genome integrity at stalled replication forks. Bansbach CE, Bétous R, Lovejoy CA, Glick GG, Cortez D. Genes Dev; 2009 Oct 15; 23(20):2405-14. PubMed ID: 19793861 [Abstract] [Full Text] [Related] Page: [Next] [New Search]